Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akili, Inc. - Common Stock (NQ: AKLI )

1.120 -0.120 (-9.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 97,911
Open 1.210
Bid (Size) 1.020 (4)
Ask (Size) 1.190 (1)
Prev. Close 1.240
Today's Range 1.120 - 1.240
52wk Range 0.8551 - 37.58
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Akili Reports First Quarter 2023 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 74.2% to $0.2701 in pre-market trading after gaining around 7% on Monday. 
Via Benzinga

Performance

YTD
+1.82%
+1.82%
1 Month
+0.90%
+0.90%
3 Month
-30.43%
-30.43%
6 Month
-23.29%
-23.29%
1 Year
-84.34%
-84.34%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From PureTech Health plc
Via Business Wire
Game-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioning
Via Benzinga
RIVN Stock Alert: Rivian Preps for Georgia Manufacturing Facility
Via InvestorPlace
Why Is Akili (AKLI) Stock Up 21% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From Akili, Inc.
Via Business Wire
Where Akili Stands With Analysts
Via Benzinga
Expert Ratings for Akili
Via Benzinga
Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022
Via Benzinga
Akili to Participate in the Cowen 43rd Annual Health Care Conference
From Akili, Inc.
Via Business Wire
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
From Akili, Inc.
Via Business Wire
Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer
From Akili, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.